Zobrazeno 1 - 10
of 26
pro vyhledávání: '"D C van Gent"'
Autor:
W. Dinjens, Titia G. Meijer, Nicole S. Verkaik, D C van Gent, C.H.M. van Deurzen, TD Den Toom, Agnes Jager, H.J. Dubbink, Roland Kanaar
Publikováno v:
Cancer Research. 79:P1-06
Introduction Better predictive biomarkers for response to Poly ADP-Ribose inhibitors (PARPi) are required, since on the one hand evidence is emerging that PARPi are also effective beyond germline BRCA mutated (gBRCAm) cancers and on the other hand gB
Autor:
Titia G. Meijer, Roland Kanaar, S. Petit, J. von der Thüsen, D C van Gent, J. de Swart, C. Groenendijk, L. Maat
Publikováno v:
Radiotherapy and Oncology. 161:S290-S291
Autor:
C.H.M. van Deurzen, Titia G. Meijer, H.J. Dubbink, D C van Gent, Nicole S. Verkaik, D. Den Toom, Agnes Jager, W. Dinjens, Roland Kanaar
Publikováno v:
ESMO Open. 3:A422-A423
Introduction Better predictive biomarkers for response to Poly ADP-Ribose inhibitors (PARPi) are required, since on the one hand evidence is emerging that PARPi are also effective beyond germline BRCA mutated (gBRCAm) cancers and on the other hand gB
Autor:
C.M.A. De Ridder, A. Van Hemelryk, Wenhao Zhang, Debra Stuurman, S. Erkens-Schulze, D C van Gent, W.M. Van Weerden, Julie Nonnekens
Publikováno v:
European Urology Supplements. 18:e3132
Enhanced radiosensitization by apalutamide via suppression of DNA damage response in prostate cancer
Autor:
Wenhao Zhang, H. Chtatou, C.A. Liao, Luca Incrocci, D C van Gent, W.M. Van Weerden, Julie Nonnekens
Publikováno v:
European Urology Supplements. 18:e3077
Autor:
David J. Chen, Marco Durante, G. Obe, S. Conrad, D C van Gent, Adayapalam T. Natarajan, Joel S. Bedford, Michael N. Cornforth
Publikováno v:
Mutation Research. Genetic Toxicology and Environmental Mutagenesis, 756(1-2), 5-13. Elsevier
Despite many years of experimental studies on radiation-induced chromosomal aberrations, and the recent progress in elucidating the molecular mechanisms of the DNA damage response, the link between DNA double-strand break repair and its expression as
Autor:
N J F van den Broek, Judith Campisi, D Putavet, D C van Gent, Boudewijn M.T. Burgering, P L J de Keizer, J.H.J. Hoeijmakers, M P Baar, Arjan B. Brenkman, K.A.T. Naipal, Flore Kruiswijk, Renuka Sivapatham, P.J. van der Spek, Wim H. J. Kruit, Sebastian C. Hasenfuss
Publikováno v:
Oncogene, 35(17), 2166-2177. Nature Publishing Group
Oncogene
Oncogene, 35(17), 2166. Nature Publishing Group
Oncogene
Oncogene, 35(17), 2166. Nature Publishing Group
Melanoma is the most lethal form of skin cancer and successful treatment of metastatic melanoma remains challenging. BRAF/MEK inhibitors only show a temporary benefit due to rapid occurrence of resistance, whereas immunotherapy is mainly effective in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d159499dd1b43e3fd7972e28f4a7040
https://pure.eur.nl/en/publications/65ad3aa2-05f7-42e8-9673-cab4e71557c6
https://pure.eur.nl/en/publications/65ad3aa2-05f7-42e8-9673-cab4e71557c6
Autor:
Albert Pastink, Hanna IJspeert, M.E.L. van der Burg, A.C. Lankester, M.J.D. van Tol, Qiang Pan-Hammarström, Corry M.R. Weemaes, D C van Gent, Wouter W. Wiegant, Adilia Warris, J.M. van den Berg, M C van Zelm, J. J. M. Van Dongen
Publikováno v:
Genes and immunity, 12(6), 434-444. Nature Publishing Group
Genes and Immunity, 12(6), 434-444. Nature Publishing Group
Genes and Immunity, 12(6), 434-444
Genes and Immunity
Genes and Immunity, 12, 434-44
Genes and Immunity, 12, 6, pp. 434-44
Genes and Immunity, 12(6), 434-444. Nature Publishing Group
Genes and Immunity, 12(6), 434-444
Genes and Immunity
Genes and Immunity, 12, 434-44
Genes and Immunity, 12, 6, pp. 434-44
Artemis deficiency is known to result in classical T-B- severe combined immunodeficiency (SCID) in case of Artemis null mutations, or Omenn's syndrome in case of hypomorphic mutations in the Artemis gene. We describe two unrelated patients with a rel
Publikováno v:
ESMO Open. 3:A26
Introduction The DNA damage response is a powerful tool of the cell to protect the genome by preventing replication of genetic mutations. A well-known defect in DNA repair is caused by mutations in the BRCA gene, present in several hereditary breast
Autor:
Agnes Jager, Jwm Martens, Anieta M. Sieuwerts, Nicole S. Verkaik, Titia G. Meijer, H.J. Dubbink, D C van Gent, Roland Kanaar, C.H.M. van Deurzen
Publikováno v:
ESMO Open. 3:A412
Introduction Tumours of germline BRCA1/2 mutated carriers show homologous recombination (HR) deficiency (HRD), resulting in impaired DNA double strand break (DSB) repair and high sensitivity to Poly-(ADP-Ribose)-Polymerase (PARP) inhibitors. Although